Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.08 USD | -8.30% | -4.70% | 0.00% |
May. 14 | Metagenomi, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target | MT |
Financials (USD)
Sales 2024 * | 39.33M | Sales 2025 * | 31.45M | Capitalization | 228M |
---|---|---|---|---|---|
Net income 2024 * | -112M | Net income 2025 * | -144M | EV / Sales 2024 * | 5.79 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.24 x |
P/E ratio 2024 * |
-1.81
x | P/E ratio 2025 * |
-1.87
x | Employees | 237 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.51% |
1 day | -8.30% | ||
1 week | -4.70% | ||
Current month | -4.70% | ||
1 month | -5.88% | ||
3 months | -49.33% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 6.08 | -8.30% | 57,498 |
24-06-06 | 6.63 | +1.22% | 15,222 |
24-06-05 | 6.55 | -0.15% | 15,221 |
24-06-04 | 6.56 | -1.94% | 21,565 |
24-06-03 | 6.69 | +4.86% | 270,022 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 228M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- MGX Stock